Cargando…

Angiotensin‐Converting Enzyme Inhibitor Prescription for Patients With Single Ventricle Physiology Enrolled in the NPC‐QIC Registry

BACKGROUND: The routine use of angiotensin‐converting enzyme inhibitors (ACEI) during palliation of hypoplastic left heart syndrome is controversial. We sought to describe ACEI prescription in the interstage between stage 1 palliation (stage I Norwood procedure) discharge and stage 2 palliation (sta...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hansen, Jesse E., Brown, David W., Hanke, Samuel P., Bates, Katherine E., Tweddell, James S., Hill, Garick, Anderson, Jeffrey B.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7660880/ https://www.ncbi.nlm.nih.gov/pubmed/32384002 http://dx.doi.org/10.1161/JAHA.119.014823

Ejemplares similares

Human milk feeding and direct breastfeeding improve outcomes for infants with single ventricle congenital heart disease: Propensity score matched analysis of the NPC-QIC registry
por: Elgersma, Kristin M., et al.
Publicado: (2023)

Human Milk Feeding and Direct Breastfeeding Improve Outcomes for Infants With Single Ventricle Congenital Heart Disease: Propensity Score‐Matched Analysis of the NPC‐QIC Registry
por: Elgersma, Kristin M., et al.
Publicado: (2023)

Quick identification of acute chest pain patients study (QICS)
por: Willemsen, Hendrik M, et al.
Publicado: (2009)

Angiotensin-Converting Enzyme-2
por: Clarke, Nicola E., et al.
Publicado: (2013)

Angiotensin Converting Enzymes
por: Wong, Marty K.S.
Publicado: (2016)

Angiotensin converting enzyme
por: Wong, Marty Kwok-Shing
Publicado: (2021)

Prescription of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blocking Agents in Australia During the COVID-19 Pandemic
por: Khattak, Z., et al.
Publicado: (2021)

Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism
por: Meurs, Kathryn M, et al.
Publicado: (2017)

Change in prescription pattern as a potential marker for adverse drug reactions of angiotensin converting enzyme inhibitors
por: Mahmoudpour, Seyed Hamidreza, et al.
Publicado: (2015)

Dietary Potassium Downregulates Angiotensin-I Converting Enzyme, Renin, and Angiotensin Converting Enzyme 2
por: Vio, Carlos P., et al.
Publicado: (2020)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Impact of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on COVID-19 in a western population. CARDIOVID registry
por: López-Otero, Diego, et al.
Publicado: (2021)

Angiotensin-Converting Enzyme 2: The First Decade
por: Clarke, Nicola E., et al.
Publicado: (2012)

Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Gersh, Felice L.
Publicado: (2020)

Increase in prescription rate of angiotensin-converting enzyme inhibitors or angiotensin receptor blocker for hospitalized patients with acute myocardial infarction and left ventricular systolic dysfunction
por: Makdisse, MRP, et al.
Publicado: (2007)

Angiotensin-Converting Enzyme Inhibitors and Angioedema
por: Sánchez-Borges, Mario, et al.
Publicado: (2010)

Angiotensin-converting Enzyme Genetic Polymorphism
por: Wiwanitkit, Somsri, et al.
Publicado: (2014)

In reply—Angiotensin-Converting Enzyme 2 and the Resolution of Inflammation: In Support of Continuation of Prescribed Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Renin‐angiotensin aldosterone profile before and after angiotensin‐converting enzyme‐inhibitor administration in dogs with angiotensin‐converting enzyme gene polymorphism
por: Adin, Darcy, et al.
Publicado: (2020)

Increasing angiotensin-converting enzyme concentrations and absent angiotensin-converting enzyme activity are associated with adverse kidney outcomes in pediatric septic shock
por: Pode-Shakked, Naomi, et al.
Publicado: (2023)

Effect of angiotensin converting enzyme inhibitors and angiotensin receptor blockers on hemoglobin levels
por: Ajmal, Adnan, et al.
Publicado: (2013)

The Fetal Safety of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers
por: Moretti, Myla E., et al.
Publicado: (2012)

Not just angiotensinases: new roles for the angiotensin-converting enzymes
por: Lambert, Daniel W., et al.
Publicado: (2009)

The association of angiotensin-converting enzyme with biomarkers for Alzheimer’s disease
por: Jochemsen, Hadassa M, et al.
Publicado: (2014)

Intrarenal Distributions and Changes of Angiotensin-Converting Enzyme and Angiotensin-Converting Enzyme 2 in Feline and Canine Chronic Kidney Disease
por: MITANI, Sawane, et al.
Publicado: (2013)

Prevalence of an angiotensin-converting enzyme gene variant in dogs
por: Adin, D. B., et al.
Publicado: (2021)

Tissue Specificity of Human Angiotensin I-Converting Enzyme
por: Kryukova, Olga V., et al.
Publicado: (2015)

Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Angiotensin-Converting Enzyme 2 Levels: A Comprehensive Analysis Based on Animal Studies
por: Kriszta, Gábor, et al.
Publicado: (2021)

Regulation of Cardiovascular Control Mechanisms by Angiotensin-(1–7) and Angiotensin-Converting Enzyme 2
por: Ferrario, Carlos M., et al.
Publicado: (2010)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2012)

Angiotensin-I-converting enzyme and its relatives
por: Riordan, James F
Publicado: (2003)

Serum Angiotensin Converting Enzyme in Pemphigus Vulgaris
por: Robati, Reza M, et al.
Publicado: (2014)

Angiotensin Converting Enzyme Activity in Alopecia Areata
por: Namazi, Mohammad Reza, et al.
Publicado: (2014)

Angiotensin-converting enzyme 2 in lung diseases
por: Kuba, Keiji, et al.
Publicado: (2006)

Angiotensin converting enzyme polymorphism and ischemic stroke
por: Salem, Gelan M., et al.
Publicado: (2020)

Angiotensin-converting-enzyme inhibitor–induced angioedema
por: Quickfall, Danica, et al.
Publicado: (2021)

Angiotensin-converting enzyme 2 and new insights into the renin–angiotensin system
por: Lambert, Daniel W., et al.
Publicado: (2008)

Interaction Between Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Angiotensin-Converting Enzyme Inhibition on Survival in Hemodialyzed Patients
por: Kiss, István, et al.
Publicado: (2014)

Ethnic Prevalence of Angiotensin-Converting Enzyme Deletion (D) Polymorphism and COVID-19 Risk: Rationale for Use of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers
por: Sarangarajan, Rangaprasad, et al.
Publicado: (2020)

Angiotensin-(1-7), Angiotensin-Converting Enzyme 2, and New Components of the Renin Angiotensin System
por: Trask, Aaron J., et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_7t3hhghpdtr6u8rielmmiguqvu